Distinguishing features of the acute hepatic porphyrias
Type of porphyria | Enzyme deficiency | Gene | Incidence per million* | Clinical presentation | Increased haem pathway metabolites |
ALA dehydratase porphyria | ALA dehydratase | ALAD | Exceptionally rare† | Acute attacks | Urine: ALA Red cell: zinc protoporphyrin |
Acute intermittent porphyria | Hydroxymethylbilane synthase | HMBS | 0.13 | Acute attacks | Urine: ALA, PBG, uro Faeces: copro III:I ratio normal Plasma: FEP at 615–622 nm |
Hereditary coproporphyria | Coproporphyrinogen oxidase | CPOX | 0.02 | Acute attacks and/or bullae and skin fragility | Urine: ALA, PBG, copro III Faeces: copro III:I ratio>1.5 Plasma: FEP at 615–622 nm |
Variegate porphyria | Protoporphyrinogen oxidase | PPOX | 0.08 | Acute attacks and/or bullae and skin fragility | Urine: ALA, PBG, copro III Faeces: copro III:I ratio>1.5, proto>copro Plasma: FEP at 624–628 nm |
*Symptomatic incidence in European population.16
†Only eight cases reported to date.3
ALA, aminolevulinic acid; ALAD, 5-aminolaevulinic acid dehydratase; copro, coproporphyrin; FEP, fluorescence emission peak; PBG, porphobilinogen; proto, protoporphyrin; uro, uroporphyrin.